BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29508417)

  • 1. Some methods for heterogeneous treatment effect estimation in high dimensions.
    Powers S; Qian J; Jung K; Schuler A; Shah NH; Hastie T; Tibshirani R
    Stat Med; 2018 May; 37(11):1767-1787. PubMed ID: 29508417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing methods for estimation of heterogeneous treatment effects using observational data from health care databases.
    Wendling T; Jung K; Callahan A; Schuler A; Shah NH; Gallego B
    Stat Med; 2018 Oct; 37(23):3309-3324. PubMed ID: 29862536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Maximum Likelihood Estimation for Causal Inference in Observational Studies.
    Schuler MS; Rose S
    Am J Epidemiol; 2017 Jan; 185(1):65-73. PubMed ID: 27941068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous record linkage and causal inference with propensity score subclassification.
    Wortman JH; Reiter JP
    Stat Med; 2018 Oct; 37(24):3533-3546. PubMed ID: 30069901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dimensional propensity score algorithm in comparative effectiveness research with time-varying interventions.
    Neugebauer R; Schmittdiel JA; Zhu Z; Rassen JA; Seeger JD; Schneeweiss S
    Stat Med; 2015 Feb; 34(5):753-81. PubMed ID: 25488047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive contrast weighted learning for multi-stage multi-treatment decision-making.
    Tao Y; Wang L
    Biometrics; 2017 Mar; 73(1):145-155. PubMed ID: 27213913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced precision in the analysis of randomized trials with ordinal outcomes.
    Díaz I; Colantuoni E; Rosenblum M
    Biometrics; 2016 Jun; 72(2):422-31. PubMed ID: 26576013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical and scientific inference.
    Ahlbom A
    J Intern Med; 2014 Sep; 276(3):238-9. PubMed ID: 25040681
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimating the effect of treatment on binary outcomes using full matching on the propensity score.
    Austin PC; Stuart EA
    Stat Methods Med Res; 2017 Dec; 26(6):2505-2525. PubMed ID: 26329750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collaborative targeted learning using regression shrinkage.
    Schnitzer ME; Cefalu M
    Stat Med; 2018 Feb; 37(4):530-543. PubMed ID: 29094375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can we learn individual-level treatment policies from clinical data?
    Shalit U
    Biostatistics; 2020 Apr; 21(2):359-362. PubMed ID: 31742359
    [No Abstract]   [Full Text] [Related]  

  • 12. Using observational data for personalized medicine when clinical trial evidence is limited.
    Gershman B; Guo DP; Dahabreh IJ
    Fertil Steril; 2018 Jun; 109(6):946-951. PubMed ID: 29935652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing high-dimensional confounder control methods for rapid cohort studies from electronic health records.
    Low YS; Gallego B; Shah NH
    J Comp Eff Res; 2016 Mar; 5(2):179-92. PubMed ID: 26634383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulation study comparing exposure matching with regression adjustment in an observational safety setting with group sequential monitoring.
    Stratton KG; Cook AJ; Jackson LA; Nelson JC
    Stat Med; 2015 Mar; 34(7):1117-33. PubMed ID: 25510526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using pilot data to size a two-arm randomized trial to find a nearly optimal personalized treatment strategy.
    Laber EB; Zhao YQ; Regh T; Davidian M; Tsiatis A; Stanford JB; Zeng D; Song R; Kosorok MR
    Stat Med; 2016 Apr; 35(8):1245-56. PubMed ID: 26506890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Learning end-to-end patient representations through self-supervised covariate balancing for causal treatment effect estimation.
    Tesei G; Giampanis S; Shi J; Norgeot B
    J Biomed Inform; 2023 Apr; 140():104339. PubMed ID: 36940895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of modern approaches for identifying and evaluating heterogeneous treatment effects from clinical data.
    Lipkovich I; Svensson D; Ratitch B; Dmitrienko A
    Clin Trials; 2023 Aug; 20(4):380-393. PubMed ID: 37203150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From Real-World Patient Data to Individualized Treatment Effects Using Machine Learning: Current and Future Methods to Address Underlying Challenges.
    Bica I; Alaa AM; Lambert C; van der Schaar M
    Clin Pharmacol Ther; 2021 Jan; 109(1):87-100. PubMed ID: 32449163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A reference-free R-learner for treatment recommendation.
    Zhou J; Zhang Y; Tu W
    Stat Methods Med Res; 2023 Feb; 32(2):404-424. PubMed ID: 36540907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining machine learning and propensity score weighting to estimate causal effects in multivalued treatments.
    Linden A; Yarnold PR
    J Eval Clin Pract; 2016 Dec; 22(6):871-881. PubMed ID: 27421786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.